企業プロフィール
Veeva 株価・ニュース・カタリスト
- ティッカー:
- VEEV
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
281.93 USD (-1.23%)
終値
最終更新: 2026年10月1日
29.9B USD
時価総額
株価変動の要因
2026年10月1日 時点で VEEV は 1.23% 下落し、$281.93 で取引を終えました。現在のニュース監視期間内に同社の新しいニュースは確認されませんでした。
企業概要
Life Sciences Industry Cloud Company
Veeva Systems provides cloud applications, data products, artificial intelligence agents, and consulting services purpose-built for life sciences. Its customers range from emerging biotechnology companies to the world's largest pharmaceutical manufacturers.
Commercial Cloud
Veeva Commercial Cloud includes Vault CRM, content, data, analytics, and customer-engagement applications used by sales, marketing, and medical teams. The suite supports regulated interactions with healthcare professionals and coordinated product commercialization.
Development and Quality Cloud
Development Cloud and Quality Cloud support clinical operations, regulatory information, safety, quality management, training, and manufacturing documentation. These applications create a connected foundation for managing regulated content and processes across the product lifecycle.
Data and Consulting Services
Veeva combines software with reference data, patient and prescriber data products, and consulting. This integrated model helps customers implement common data standards and execute commercial and development programs on the same industry-specific platform.
AI Agents and Falcon Platform
Veeva is embedding standard and configurable agents into Vault applications while developing Falcon as an agentic labor platform for clinical, regulatory, and safety work. The strategy applies AI within governed life-sciences workflows rather than offering a general-purpose horizontal tool.
今後のカタリスト
- Initial customer go-lives for the Veeva Falcon agentic labor platform by year-end 2026.
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。